Outcome | Treatment and Outcome Series, n = 34 (%) | Imaging*, n = 15 (%) | Biomarker Studies, n = 24 (%) | Overall, n = 73 (%) |
---|---|---|---|---|
TAK-related outcomes | ||||
Remission | 7 (21) | 0 (0) | 7 (29) | 14 (19) |
Relapse | 3 (9) | 0 (0) | 1 (4) | 4 (6) |
Stable | 4 (12) | 0 (0) | 1 (4) | 5 (7) |
Activity according to definition by Kerr52 | 14 (41) | 8 (53) | 11 (46) | 36 (49) |
TAK disease activity scale (DEI.TAK/ITAS) | 2 (6) | 0 (0) | 0 (0) | 2 (3) |
Interventions (PTCA + surgery) | 23 (68) | 1 (7) | 1 (4) | 25 (34) |
Laboratory testing outcomes | ||||
ESR, CRP, or CBC | 23 (68) | 12 (80) | 21 (88) | 56 (77) |
Glucocorticoid-related outcomes | ||||
Dose or duration | 25 (96) | 7 (54) | 17 (74) | 49 (79) |
Other outcomes | ||||
Mortality | 13 (46) | 0 (0) | 0 (0) | 13 (20) |
Patient-reported assessments | 3 (11) | 0 (0) | 0 (0) | 3 (5) |
Angiography | 21 (62) | 8 (53) | 11 (46) | 40 (55) |
↵* Studies on imaging modalities other than conventional angiography. DEI.TAK/ITAS: Disease Extent Index for Takayasu’s arteritis/Indian Takayasu’s Arteritis Score; PTCA: percutaneous transluminal coronary angioplasty; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; CBC: complete blood count.